This risk is particularly serious with injectable medications, where improper storage or administration can cause significant harm
GLP-1 therapy has demonstrated sustained weight loss of 15-22% in clinical trials, making it one of the most effective tools available for metabolic health
Results vary depending on individual factors such as starting weight, metabolism, adherence to the plan, and treatment choices
Risk factors for greater lean tissue loss likely include advanced age, rapid or large absolute weight loss, low dietary protein intake, sedentary lifestyle, and comorbid conditions such as chronic kidney disease or long-standing diabetes [15]
Red flags when evaluating research chemical vendors Not all research chemical vendors are equal